Stocks Poised for Muted Open
Barron's -

Bayer says late-stage testing of a drug called asundexian used to treat heart disease would be stopped because it didn't appear to be...

Related Articles

Latest in News

More from Barron's | Machinery Agricultural Machinery Computers Consumer Electronics Desktop Computers Software Applications Software Semiconductors Measuring Precision Instruments Medical Equipment Supplies Retail Wholesale Specialty Retailing Sporting Goods Retailing Technical Services Healthcare Life Sciences Business Consumer Services Communications Software Computing Computer Hardware Industrial Electronics Industrial Goods Technology Equity Markets Commodity Financial Market News Content Types Factiva Filters C&E Exclusion Filter IWE Filter Routine Market Financial News SYND Markets North America Companies Economy & Policy Economics Federal Reserve Deere DE HP HPQ Zoom Video Communications ZM Kohl's KSS equity markets commodity financial market news content types factiva filters c&e exclusion filter iwe filter routine market financial news markets north america retail technology companies economy & policy economics federal reserve machinery agricultural machinery computers consumer electronics desktop computers software applications software semiconductors measuring precision instruments medical equipment supplies wholesale specialty retailing sporting goods retailing technical services healthcare life sciences business consumer services communications software computing computer hardware industrial electronics industrial goods Stock S&P 500 Futures contract Thanksgiving Dow Jones Industrial Average Nasdaq